May 3, 2010
CASE CCC IN THE NEWS
Study: Options for Post-Menopausal Breast Cancer Prevention
Prostate Cancer Treatment Approved by FDA
FDA OKs Provenge for Prostate Cancer Therapy
FDA Approves Immune-boosting Therapy for Prostate Cancer
Oncology Times Welcomes New Advisory Editors: Mikkael Sekeres, MD, MS Ramaswamy Govindan, MD...
Letters: How to Fix the Cancer Trials Program
To the Editor:
As a clinical investigator for more than 20 years, I have personally experienced the successes and frustrations associated with the publicly financed clinical trials system.
It is well recognized that clinical trials are critical to improving cancer care. But an important point not mentioned in your editorial is that cancer patient participation in clinical trials is abysmally low. In fact, only a small percentage of all adult cancer patients takes part in clinical trials. This low participation rate comes at a time when scientific discoveries and technologies are providing the opportunity to test an unprecedented number of promising new treatments.
There are many reasons for this low participation rate. As you note, operational inefficiencies in the nation's clinical trials infrastructure and inadequate financial support for clinical investigation are certainly partly to blame. But as a society we have done a poor job emphasizing the importance of clinical research as an integral component of high-quality cancer care.
Taking part in a clinical trial offers the opportunity to advance cancer treatment, while gaining access to the latest innovations under the careful watch of an infrastructure designed to ensure patient safety. It is time that we take note of the marketing skills that have contributed to the adoption of so many unhealthy behaviors (smoking, fast food), and apply them to a more healthful goal: widespread recognition that cancer clinical trials represent the best treatments we have to offer.
Neal J. Meropol
The writer is chief, Division of Hematology and Oncology, University Hospitals Ireland Cancer Center at Case Western Reserve University.
More information on NCI clinical trials is available in the Institute of Medicine April 2010 report, A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program.
Dr. Joseph Baar has been nominated as a finalist for the Crain's Business Cleveland 2010 Health Care Hero in the Advancements in Health Care category. The winner will be announced at a May 6 luncheon ceremony.
NIH NEWS– ARRA Awards Are Eligible for No Cost Extensions
Francis Collins, Director of the NIH, announced that ARRA Awards are eligible for no cost extensions. The NIH treats ARRA awards under the same terms as other awards under the NIH Grants Policy Statement including the authority to extend the final budget period of a previously approved project period for up to 12 months without additional funds, i.e., provide a twelve month no cost extension, without prior approval. However, requests for a second no cost extension will likely not receive approval as the intent of the ARRA funding is to provide a near term stimulus to the economy.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING PRESENTATIONS & POSTERS
The Cancer Center is attempting to track members who are part of the formal program or presenting a poster at the ASCO Annual Meeting, June 4-8 in Chicago. Please send information to email@example.com.
RACE FOR THE PLACE– Join Our Team
Come walk/run with us at the Race for the Place, an event to support the Gathering Place on Sunday, June 6 at Beachwood Place Mall. Registration opens at 7:30 am; race begins with the Survivor Ceremony at 9 am. Email firstname.lastname@example.org for more information.
CALL FOR ABSTRACTS– Cancer–Related Research
The Case CCC Retreat will feature a poster presentation session the evening of July 9. All graduate students, postdocs and fellows conducting cancer research are invited to submit abstracts. The Retreat Program Committee will review abstracts based on the relationship to cancer, novelty, significance of findings, and clarity. Monetary prizes will be awarded. More information is available on the Call for Abstracts page.
Deadline to submit abstracts to email@example.com is Friday, May 21 at 5 pm.
**All events are open to anyone interested in attending
Physiology & Biophysics Seminar
Center for Translational Neuroscience
Case CCC Conference: Women's Cancer: Screening and Prevention in 2010
Hem/Onc Fellows Seminar
Taussig Cancer Institute Grand Rounds
Cell Biology Seminar Series
Cancer Center Research in Progress Seminar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Case CCC Scientific Retreat
ADDITIONAL UPCOMING SEMINARS & EVENTS
Midwest Blood Club Symposium
Business Education Course: "The Business of Regenerative Medicine: From Stem Cells to the Market Place"
Advanced Training Institute on Health Behavior Theory
International Symposium on Breast Cancer Prevention: Nutrition, Communication and Public Policy
FACULTY CANDIDATE SEARCH– Associate Director for Basic Research
The Case CCC is currently accepting applications for the position of Associate Director for Basic Research. As we continue our search, we ask that people in the Cancer Center community encourage any qualified candidate to apply for the position. If you would like to nominate someone for the position, please contact Tracy Rehl (firstname.lastname@example.org).
CASE CCC ON FACEBOOK AND LINKEDIN– Join Us!
We are always trying to foster communication and collaboration across the cancer center community any way that we can. The Case CCC has set up a page on Facebook and LinkedIn, so please become a fan of us on Facebook or join our group on LinkedIn, and encourage others to do so as well. Please help us spread the word.
We encourage you to post events, relevant news articles, items of discussion, etc… Your feedback is appreciated!
PREVIOUSLY ANNOUNCED OPPORTUNITIES
DOD BCRP Idea Award
DOD PCRP Prostate Cancer Training Award
NIH Bulletin – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.